Added to YB: 2020-12-16
Pitch date: 2020-12-16
NBSE:US [bullish]
NeuBase Therapeutics, Inc.
-99.79%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes.
Market Cap
EUR 1.4M
Pitch Price
EUR 181.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-0.02
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
NeuBase Therapeutics Inc NBSE:US
A summary for this pitch has not been created yet.
Read full article (0 min)